Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.8.0.1
Consolidated Statements of Operations - USD ($)
12 Months Ended
Dec. 31, 2017
Dec. 31, 2016
Revenue:    
Products, services, other $ 2,065,891 $ 1,794,749
Grant revenue 174,607 181,738
Total revenue 2,240,498 1,976,487
Costs and expenses:    
Cost of products and services 1,273,354 834,012
Research and development 988,597 1,183,011
Selling and marketing 1,209,334 872,365
General and administrative 3,416,261 2,822,752
Total operating costs and expenses 6,887,546 5,712,140
Operating loss (4,647,048) (3,735,653)
Other (expense) income:    
Interest expense (6,055,420) (4,501,186)
Other expense (5,674) (1,112)
Impairment loss on investment (6,069) (373,682)
Gain on extinguishment of debt 185,452 5,044
Incentive warrants for warrant exercises (186,802)
Change in fair value of derivative liabilities 5,904,649
Total other (expense) income (6,068,513) 1,028,669
Net loss $ (10,715,561) $ (2,706,984)
Net loss per share - basic and diluted $ (9.62) $ (2.97)
Weighted average common stock shares outstanding used in the basic and diluted net loss per share calculation 1,114,225 911,312